[Federal Register: January 4, 2005 (Volume 70, Number 2)]
[Notices]
[Page 389]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr04ja05-74]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated June 28, 2004, and published in the Federal
Register on July 13, 2004, (69 FR 42067-42068), Cedarburg
Pharmaceuticals, Inc., 870 Badger Circle, Grafton, Wisconsin 53024,
made application by renewal to the Drug Enforcement Administration
(DEA) to be registered as a bulk manufacturer of the basic classes of
controlled substances listed below:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)................ I
Dihydromorphine (9145)...................... I
Hydromorphone (9150)........................ II
Fentanyl (9801)............................. II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Cedarburg Pharmaceuticals, Inc. to manufacture the listed basic classes
of controlled substances is consistent with the public interest at this
time. DEA has investigated Cedarburg Pharmaceuticals, Inc. to ensure
that the company's registration is consistent with the public interest.
The investigation has included inspection and testing of the company's
physical security systems, verification of the company's compliance
with state and local laws, and a review of the company's background and
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with
21 CFR 1301.33, the above named company is granted registration as a
bulk manufacturer of the basic classes of controlled substances listed.
Dated: December 21, 2004.
William J. Walker,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 05-66 Filed 1-3-05; 8:45 am]
BILLING CODE 4410-09-P